Celanese Corporation (NYSE: CE), a global chemical and specialty materials company, today reported first quarter GAAP diluted earnings per share of $1.88 and adjusted earnings per share of $2.29 on net sales of $1.5 billion. Despite the impact of coronavirus (COVID-19) on already weak demand levels in China that extended beyond Chinese New Year, the Company delivered sequential growth in operating profit and adjusted EBIT due to the resiliency of the Engineered Materials and Acetyl Chain commercial models and continued stability in Acetate Tow. Celanese generated robust operating cash flow of $259 million and free cash flow of $135 million. The Company retains substantial financial flexibility as a result of continued liquidity and balance sheet strength. Celanese has identified and implemented structural cost and capital reduction actions and continues to execute a disciplined cash deployment strategy that will position it for growth after current challenges subside.
"Our culture at Celanese has long been action-oriented, which is even more critical in this environment. I am proud of the strong spirit of our employees across the world whose resolve and determination enabled us to deliver a healthy first quarter performance in these unprecedented times. We expect that reduced consumer activity, which started in the latter half of the first quarter, particularly in the Western Hemisphere, will work its way through relevant value chains to impact our second quarter demand more meaningfully. We continue to focus on those items within our control and will take further actions to maximize our cash generation in a weaker than anticipated demand environment and position ourselves for recovery," said Lori Ryerkerk, chairman and chief executive officer.
First Quarter 2020 Financial Highlights:
|
Three Months Ended |
||||||||||
|
March 31,
|
|
December 31,
|
|
March 31,
|
||||||
|
(unaudited) |
||||||||||
|
(In $ millions, except per share data) |
||||||||||
Net Sales |
|
|
|
|
|
||||||
Engineered Materials |
563 |
|
|
539 |
|
|
663 |
|
|||
Acetate Tow |
129 |
|
|
148 |
|
|
166 |
|
|||
Acetyl Chain |
799 |
|
|
771 |
|
|
889 |
|
|||
Intersegment Eliminations |
(31 |
) |
|
(26 |
) |
|
(31 |
) |
|||
Total |
1,460 |
|
|
1,432 |
|
|
1,687 |
|
|||
|
Three Months Ended |
||||||||||
|
March 31,
|
|
December 31,
|
|
March 31,
|
||||||
|
(unaudited) |
||||||||||
|
(In $ millions, except per share data) |
||||||||||
Operating Profit (Loss) |
|
|
|
|
|
||||||
Engineered Materials |
102 |
|
|
88 |
|
|
144 |
|
|||
Acetate Tow |
27 |
|
|
22 |
|
|
40 |
|
|||
Acetyl Chain |
135 |
|
|
108 |
|
|
202 |
|
|||
Other Activities |
(70 |
) |
|
(150 |
) |
|
(66 |
) |
|||
Total |
194 |
|
|
68 |
|
|
320 |
|
|
Three Months Ended |
||||||||||
|
March 31,
|
|
December 31,
|
|
March 31,
|
||||||
|
(unaudited) |
||||||||||
|
(In $ millions, except per share data) |
||||||||||
Net Earnings (Loss) |
220 |
|
|
45 |
|
|
338 |
|
|||
|
|
|
|
|
|
||||||
Adjusted EBIT(1) |
|
|
|
|
|
||||||
Engineered Materials |
165 |
|
|
136 |
|
|
183 |
|
|||
Acetate Tow |
67 |
|
|
54 |
|
|
72 |
|
|||
Acetyl Chain |
139 |
|
|
144 |
|
|
203 |
|
|||
Other Activities |
(29 |
) |
|
(31 |
) |
|
(37 |
) |
|||
Total |
342 |
|
|
303 |
|
|
421 |
|
|||
|
|
|
|
|
|
||||||
Equity Earnings and Dividend Income, Other Income (Expense) |
|
|
|
|
|
||||||
Engineered Materials |
53 |
|
|
45 |
|
|
46 |
|
|||
Acetate Tow |
37 |
|
|
24 |
|
|
32 |
|
|||
|
|
|
|
|
|
||||||
Operating EBITDA(1) |
425 |
|
|
387 |
|
|
502 |
|
|||
Diluted EPS - continuing operations |
$ |
1.88 |
|
|
$ |
0.35 |
|
|
$ |
2.64 |
|
Diluted EPS - total |
$ |
1.82 |
|
|
$ |
0.36 |
|
|
$ |
2.63 |
|
Adjusted EPS(1) |
$ |
2.29 |
|
|
$ |
1.99 |
|
|
$ |
2.62 |
|
|
|
|
|
|
|
||||||
Net cash provided by (used in) investing activities |
(128 |
) |
|
(168 |
) |
|
(177 |
) |
|||
Net cash provided by (used in) financing activities |
(16 |
) |
|
(199 |
) |
|
(130 |
) |
|||
Net cash provided by (used in) operating activities |
259 |
|
|
326 |
|
|
307 |
|
|||
Free cash flow(1) |
135 |
|
|
179 |
|
|
224 |
|
|||
______________________________ (1) See "Non-US GAAP Financial Measures" below. |
|||||||||||
First Quarter 2020 Highlights:
First Quarter 2020 Business Segment Overview
Engineered Materials (EM)
Engineered Materials generated first quarter net sales of $563 million, an increase of 4 percent over the fourth quarter of 2019 on higher volume. The business successfully offset lower sequential volume in Asia as a result of Chinese New Year and the impact of COVID-19 with robust growth in the Western Hemisphere driven by volume ramp-up of recent project wins, which also partially offset the demand softness that began to materialize towards the end of the first quarter. The EM business was able to generate GAAP operating profit of $102 million and adjusted EBIT of $165 million. First quarter operating profit margin of 18.1 percent and adjusted EBIT margin of 29.3 percent, increased by 180 basis points and 410 basis points, respectively, over the prior quarter. Margin expansion was driven by sustained pricing levels amid sequentially lower raw material costs and incremental contributions from affiliate earnings. As a result, the overall business grew GAAP operating profit and adjusted EBIT on a sequential basis.
Acetyl Chain
The Acetyl Chain recorded net sales of $799 million in the first quarter, as sequential volume growth of 5 percent partially offset a continued decline in industry pricing resulting from weakness in Asian demand and underlying raw materials. GAAP operating profit of $135 million and adjusted EBIT of $139 million with operating profit margin of 16.9 percent and adjusted EBIT margin of 17.4 percent were lower than the prior quarter due primarily to weaker industry pricing. Income was negatively affected by the COVID-19 crisis by approximately $15 million, largely through customer order cancellations in March. The Acetyl Chain was able to utilize its global supply network to redirect incremental acetic acid to the Western Hemisphere in response to the continued Chinese acetic acid pricing declines and lower than expected country demand. The Acetyl Chain also continued to execute its derivatization strategy to place 8 percent more tonnage downstream in VAM compared to the fourth quarter. The business was also able to successfully complete the first full turnaround of the methanol joint venture at Clear Lake within the quarter at a cost of approximately $15 million and does not anticipate another turnaround with this unit for four years.
Acetate Tow
Acetate Tow reported GAAP operating profit of $27 million and adjusted EBIT of $67 million in the first quarter, improvements over the fourth quarter of 2019 as demand remained resilient. The business continues to deliver consistent earnings performance over the last two years. Dividends from affiliates were $37 million in the first quarter, higher sequentially due to the timing of dividend payments and consistent with the same period last year.
Cash Flow and Tax
The Company delivered strong first quarter operating cash flow and free cash flow of $259 million and $135 million, respectively, driven by continued business performance and focused working capital initiatives. Capital expenditures in the quarter were $119 million, including several growth and productivity-based projects in Engineered Materials and the Acetyl Chain. The Company now anticipates full year capital expenditures of less than $350 million, a reduction from prior expectations of $500 million. For the quarter, a total of $224 million in cash was returned to shareholders, including $150 million in share repurchases and $74 million in dividends. The effective US GAAP tax rate was 22 percent in the first quarter compared to 12 percent in the same quarter of last year, primarily due to currency movements and changes in the jurisdictional mix of earnings. The tax rate for adjusted EPS was 13 percent in the quarter unchanged from the full year 2019 adjusted tax rate.
Outlook
"As a result of our work over many years to improve our businesses and strengthen our balance sheet, we are well-positioned to meet the current macro-economic challenges," continued Ryerkerk. "We anticipate that we will generate $300 to $400 million of incremental cash due specifically to the actions we are currently taking on productivity, working capital management, and capital expenditures prioritization which allow us to offset meaningful demand and earnings challenges and deliver exceptionally resilient cash flow in 2020. We remain committed to keeping our employees safe, meeting our customers' needs, and delivering sustained value for our shareholders in any environment."
Due to uncertainties regarding the duration and impact of the coronavirus (COVID-19) pandemic, Celanese is suspending its previously announced annual adjusted earnings per share guidance for 2020.
The Company's prepared remarks related to the first quarter will be posted on its website at investors.celanese.com under Financial Information/Financial Document Library after market close on April 27, 2020. Information about Non-US GAAP measures is included in a Non-US GAAP Financial Measures and Supplemental Information document posted on our website. See "Non-GAAP Financial Measures" below.
Celanese Corporation is a global chemical leader in the production of differentiated chemistry solutions and specialty materials used in most major industries and consumer applications. Our businesses use the full breadth of Celanese's global chemistry, technology and commercial expertise to create value for our customers, employees, shareholders and the corporation. As we partner with our customers to solve their most critical business needs, we strive to make a positive impact on our communities and the world through The Celanese Foundation. Based in Dallas, Celanese employs approximately 7,700 employees worldwide and had 2019 net sales of $6.3 billion. For more information about Celanese Corporation and its product offerings, visit www.celanese.com or our blog at www.celaneseblog.com.
Forward-Looking Statements
This release may contain "forward-looking statements," which include information concerning the Company's plans, objectives, goals, strategies, future revenues or performance, capital expenditures, financing needs and other information that is not historical information. All forward-looking statements are based upon current expectations and beliefs and various assumptions. There can be no assurance that the Company will realize these expectations or that these beliefs will prove correct. There are a number of risks and uncertainties that could cause actual results to differ materially from the results expressed or implied in the forward-looking statements contained in this release. These risks and uncertainties include, among other things: changes in general economic, business, political and regulatory conditions in the countries or regions in which we operate; the length and depth of product and industry business cycles, particularly in the automotive, electrical, textiles, electronics and construction industries; changes in the price and availability of raw materials, particularly changes in the demand for, supply of, and market prices of ethylene, methanol, natural gas, wood pulp and fuel oil and the prices for electricity and other energy sources; the ability to pass increases in raw material prices on to customers or otherwise improve margins through price increases; the ability to maintain plant utilization rates and to implement planned capacity additions and expansions; the ability to reduce or maintain their current levels of production costs and to improve productivity by implementing technological improvements to existing plants; the ability to identify desirable potential acquisition targets and to consummate acquisition or investment transactions consistent with the Company's strategy; increased price competition and the introduction of competing products by other companies; market acceptance of our technology; the ability to obtain governmental approvals and to construct facilities on terms and schedules acceptable to the Company; changes in tariffs, tax rates or legislation; changes in the degree of intellectual property and other legal protection afforded to our products or technologies, or the theft of such intellectual property; compliance and other costs and potential disruption or interruption of production or operations due to accidents, interruptions in sources of raw materials, cyber security incidents, terrorism or political unrest, public health crises (including, but not limited to, the COVID-19 pandemic), or other unforeseen events or delays in construction or operation of facilities, including as a result of geopolitical conditions, the occurrence of acts of war or terrorist incidents or as a result of weather or natural disasters or other crises including public health crises; potential liability for remedial actions and increased costs under existing or future environmental regulations, including those relating to climate change; potential liability resulting from pending or future litigation, or from changes in the laws, regulations or policies of governments or other governmental activities in the countries in which we operate; changes in currency exchange rates and interest rates; our level of indebtedness, which could diminish our ability to raise additional capital to fund operations or limit our ability to react to changes in the economy or the chemicals industry; and various other factors discussed from time to time in the Company's filings with the Securities and Exchange Commission.
The extent to which COVID-19 will adversely impact our business, financial condition and results of operations will depend on numerous evolving factors, which are highly uncertain, rapidly changing and cannot be predicted, including: the duration and scope of the outbreak; governmental, business and individual actions that have been and continue to be taken in response to the outbreak, including social distancing, work-at-home, stay-at-home and shelter-in-place orders and shutdowns, travel restrictions and quarantines; the effect of the outbreak on our customers, suppliers, supply chain and other business partners; our ability during the outbreak to provide our products and services, including the health and well-being of our employees; business disruptions caused by actual or potential plant, workplace and office closures, and an increased reliance on employees working from home, disruptions to or delays in ongoing laboratory and product testing, experiments and operations, staffing shortages, travel limitations, cyber security and data accessibility, or communication or mass transit disruptions, any of which could adversely impact our business operations or delay necessary interactions with local regulators, manufacturing sites and other important agencies and contractors; the ability of our customers to pay for our products and services during and following the outbreak; the impact of the outbreak on the financial markets and economic activity generally; our ability to access usual sources of liquidity on reasonable terms; and our ability to comply with the financial covenant in our Credit Agreement if a material economic downturn results in increased indebtedness or substantially lower EBITDA.
Any forward-looking statement speaks only as of the date on which it is made, and the Company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on which it is made or to reflect the occurrence of anticipated or unanticipated events or circumstances.
Non-GAAP Financial Measures
Presentation
This document presents the Company's three business segments, Engineered Materials, Acetate Tow and Acetyl Chain.
Use of Non-US GAAP Financial Information
This release uses the following Non-US GAAP measures: adjusted EBIT, adjusted EBIT margin, operating EBITDA, adjusted earnings per share and free cash flow. These measures are not recognized in accordance with US GAAP and should not be viewed as an alternative to US GAAP measures of performance or liquidity. The most directly comparable financial measure presented in accordance with US GAAP in our consolidated financial statements for adjusted EBIT and operating EBITDA is net earnings (loss) attributable to Celanese Corporation; for adjusted EBIT margin is operating margin; for adjusted earnings per share is earnings (loss) from continuing operations attributable to Celanese Corporation per common share-diluted; and for free cash flow is net cash provided by (used in) operations.
Definitions of Non-US GAAP Financial Measures
Reconciliation of Non-US GAAP Financial Measures
Reconciliations of the Non-US GAAP financial measures used in this press release to the comparable US GAAP financial measure, together with information about the purposes and uses of Non-US GAAP financial measures, are included in our Non-US GAAP Financial Measures and Supplemental Information document filed as an exhibit to our Current Report on Form 8-K filed with the SEC on or about April 27, 2020 and also available on our website at investors.celanese.com under Financial Information/Financial Document Library.
Results Unaudited
The results in this document, together with the adjustments made to present the results on a comparable basis, have not been audited and are based on internal financial data furnished to management. Quarterly results should not be taken as an indication of the results of operations to be reported for any subsequent period or for the full fiscal year.
Supplemental Information
Additional information about our prior period performance is included in our Quarterly Reports on Form 10-Q and in our Non-US GAAP Financial Measures and Supplemental Information document.
Consolidated Statements of Operations - Unaudited
|
Three Months Ended |
|||||||
|
March 31,
|
|
December 31,
|
|
March 31,
|
|||
|
(In $ millions, except share and per share data) |
|||||||
Net sales |
1,460 |
|
|
1,432 |
|
|
1,687 |
|
Cost of sales |
(1,112 |
) |
|
(1,116 |
) |
|
(1,234 |
) |
Gross profit |
348 |
|
|
316 |
|
|
453 |
|
Selling, general and administrative expenses |
(125 |
) |
|
(125 |
) |
|
(120 |
) |
Amortization of intangible assets |
(5 |
) |
|
(6 |
) |
|
(6 |
) |
Research and development expenses |
(17 |
) |
|
(17 |
) |
|
(16 |
) |
Other (charges) gains, net |
(6 |
) |
|
(102 |
) |
|
4 |
|
Foreign exchange gain (loss), net |
(1 |
) |
|
2 |
|
|
5 |
|
Operating profit (loss) |
194 |
|
|
68 |
|
|
320 |
|
Equity in net earnings (loss) of affiliates |
57 |
|
|
48 |
|
|
50 |
|
Non-operating pension and other postretirement employee benefit (expense) income |
28 |
|
|
(71 |
) |
|
17 |
|
Interest expense |
(28 |
) |
|
(28 |
) |
|
(31 |
) |
Interest income |
2 |
|
|
2 |
|
|
1 |
|
Dividend income - equity investments |
37 |
|
|
24 |
|
|
32 |
|
Other income (expense), net |
2 |
|
|
(2 |
) |
|
(4 |
) |
Earnings (loss) from continuing operations before tax |
292 |
|
|
41 |
|
|
385 |
|
Income tax (provision) benefit |
(65 |
) |
|
3 |
|
|
(46 |
) |
Earnings (loss) from continuing operations |
227 |
|
|
44 |
|
|
339 |
|
Earnings (loss) from operation of discontinued operations |
(7 |
) |
|
1 |
|
|
(1 |
) |
Income tax (provision) benefit from discontinued operations |
— |
|
|
— |
|
|
— |
|
Earnings (loss) from discontinued operations |
(7 |
) |
|
1 |
|
|
(1 |
) |
Net earnings (loss) |
220 |
|
|
45 |
|
|
338 |
|
Net (earnings) loss attributable to noncontrolling interests |
(2 |
) |
|
(2 |
) |
|
(1 |
) |
Net earnings (loss) attributable to Celanese Corporation |
218 |
|
|
43 |
|
|
337 |
|
Amounts attributable to Celanese Corporation |
|
|
|
|
|
|||
Earnings (loss) from continuing operations |
225 |
|
|
42 |
|
|
338 |
|
Earnings (loss) from discontinued operations |
(7 |
) |
|
1 |
|
|
(1 |
) |
Net earnings (loss) |
218 |
|
|
43 |
|
|
337 |
|
Earnings (loss) per common share - basic |
|
|
|
|
|
|||
Continuing operations |
1.89 |
|
|
0.35 |
|
|
2.65 |
|
Discontinued operations |
(0.06 |
) |
|
0.01 |
|
|
(0.01 |
) |
Net earnings (loss) - basic |
1.83 |
|
|
0.36 |
|
|
2.64 |
|
Earnings (loss) per common share - diluted |
|
|
|
|
|
|||
Continuing operations |
1.88 |
|
|
0.35 |
|
|
2.64 |
|
Discontinued operations |
(0.06 |
) |
|
0.01 |
|
|
(0.01 |
) |
Net earnings (loss) - diluted |
1.82 |
|
|
0.36 |
|
|
2.63 |
|
Weighted average shares (in millions) |
|
|
|
|
|
|||
Basic |
119.3 |
|
|
120.3 |
|
|
127.5 |
|
Diluted |
119.9 |
|
|
120.9 |
|
|
128.2 |
|
Consolidated Balance Sheets - Unaudited
|
As of
|
|
As of
|
|||
|
(In $ millions) |
|||||
ASSETS |
|
|
|
|||
Current Assets |
|
|
|
|||
Cash and cash equivalents |
570 |
|
|
463 |
|
|
Trade receivables - third party and affiliates, net |
853 |
|
|
850 |
|
|
Non-trade receivables, net |
307 |
|
|
331 |
|
|
Inventories |
1,036 |
|
|
1,038 |
|
|
Marketable securities |
38 |
|
|
40 |
|
|
Other assets |
51 |
|
|
43 |
|
|
Total current assets |
2,855 |
|
|
2,765 |
|
|
Investments in affiliates |
981 |
|
|
975 |
|
|
Property, plant and equipment, net |
3,678 |
|
|
3,713 |
|
|
Operating lease right-of-use assets |
201 |
|
|
203 |
|
|
Deferred income taxes |
91 |
|
|
96 |
|
|
Other assets |
381 |
|
|
338 |
|
|
Goodwill |
1,056 |
|
|
1,074 |
|
|
Intangible assets, net |
302 |
|
|
312 |
|
|
Total assets |
9,545 |
|
|
9,476 |
|
|
LIABILITIES AND EQUITY |
|
|
|
|||
Current Liabilities |
|
|
|
|||
Short-term borrowings and current installments of long-term debt - third party and affiliates |
749 |
|
|
496 |
|
|
Trade payables - third party and affiliates |
724 |
|
|
780 |
|
|
Other liabilities |
422 |
|
|
461 |
|
|
Income taxes payable |
33 |
|
|
17 |
|
|
Total current liabilities |
1,928 |
|
|
1,754 |
|
|
Long-term debt, net of unamortized deferred financing costs |
3,356 |
|
|
3,409 |
|
|
Deferred income taxes |
258 |
|
|
257 |
|
|
Uncertain tax positions |
161 |
|
|
165 |
|
|
Benefit obligations |
568 |
|
|
589 |
|
|
Operating lease liabilities |
175 |
|
|
181 |
|
|
Other liabilities |
263 |
|
|
223 |
|
|
Commitments and Contingencies |
|
|
|
|||
Stockholders' Equity |
|
|
|
|||
Treasury stock, at cost |
(3,996 |
) |
|
(3,846 |
) |
|
Additional paid-in capital |
242 |
|
|
254 |
|
|
Retained earnings |
6,543 |
|
|
6,399 |
|
|
Accumulated other comprehensive income (loss), net |
(341 |
) |
|
(300 |
) |
|
Total Celanese Corporation stockholders' equity |
2,448 |
|
|
2,507 |
|
|
Noncontrolling interests |
388 |
|
|
391 |
|
|
Total equity |
2,836 |
|
|
2,898 |
|
|
Total liabilities and equity |
9,545 |
|
|
9,476 |
|
|
Non-US GAAP Financial Measures and Supplemental Information
April 27, 2020
In this document, the terms the "Company," "we" and "our" refer to Celanese Corporation and its subsidiaries on a consolidated basis.
Purpose
The purpose of this document is to provide information of interest to investors, analysts and other parties including supplemental financial information and reconciliations and other information concerning our use of non-US GAAP financial measures. This document is updated quarterly.
Presentation
This document presents the Company's three business segments, Engineered Materials, Acetate Tow and Acetyl Chain.
Use of Non-US GAAP Financial Measures
From time to time, management may publicly disclose certain numerical "non-GAAP financial measures" in the course of our earnings releases, financial presentations, earnings conference calls, investor and analyst meetings and otherwise. For these purposes, the Securities and Exchange Commission ("SEC") defines a "non-GAAP financial measure" as a numerical measure of historical or future financial performance, financial position or cash flows that excludes amounts, or is subject to adjustments that effectively exclude amounts, included in the most directly comparable measure calculated and presented in accordance with US GAAP, and vice versa for measures that include amounts, or are subject to adjustments that effectively include amounts, that are excluded from the most directly comparable US GAAP measure so calculated and presented. For these purposes, "GAAP" refers to generally accepted accounting principles in the United States.
Non-GAAP financial measures disclosed by management are provided as additional information to investors, analysts and other parties because the Company believes them to be important supplemental measures for assessing our financial and operating results and as a means to evaluate our financial condition and period-to-period comparisons. These non-GAAP financial measures should be viewed as supplemental to, and should not be considered in isolation or as alternatives to, net earnings (loss), operating profit (loss), operating margin, cash flow from operating activities (together with cash flow from investing and financing activities), earnings per share or any other US GAAP financial measure. These non-GAAP financial measures should be considered within the context of our complete audited and unaudited financial results for the given period, which are available on the Financial Information/Financial Document Library page of our website, investors.celanese.com. The definition and method of calculation of the non-GAAP financial measures used herein may be different from other companies' methods for calculating measures with the same or similar titles. Investors, analysts and other parties should understand how another company calculates such non-GAAP financial measures before comparing the other company's non-GAAP financial measures to any of our own. These non-GAAP financial measures may not be indicative of the historical operating results of the Company nor are they intended to be predictive or projections of future results.
Pursuant to the requirements of SEC Regulation G, whenever we refer to a non-GAAP financial measure, we will also present in this document, in the presentation itself or on a Form 8-K in connection with the presentation on the Financial Information/Financial Document Library page of our website, investors.celanese.com, to the extent practicable, the most directly comparable financial measure calculated and presented in accordance with GAAP, along with a reconciliation of the differences between the non-GAAP financial measure we reference and such comparable GAAP financial measure.
This document includes definitions and reconciliations of non-GAAP financial measures used from time to time by the Company.
Specific Measures Used
This document provides information about the following non-GAAP measures: adjusted EBIT, adjusted EBIT margin, operating EBITDA, operating EBITDA margin, operating profit (loss) attributable to Celanese Corporation, adjusted earnings per share, net debt, free cash flow and return on invested capital (adjusted). The most directly comparable financial measure presented in accordance with US GAAP in our consolidated financial statements for adjusted EBIT and operating EBITDA is net earnings (loss) attributable to Celanese Corporation; for adjusted EBIT margin and operating EBITDA margin is operating margin; for operating profit (loss) attributable to Celanese Corporation is operating profit (loss); for adjusted earnings per share is earnings (loss) from continuing operations attributable to Celanese Corporation per common share-diluted; for net debt is total debt; for free cash flow is net cash provided by (used in) operations; and for return on invested capital (adjusted) is net earnings (loss) attributable to Celanese Corporation divided by the sum of the average of beginning and end of the year short- and long-term debt and Celanese Corporation stockholders' equity.
Definitions
Supplemental Information
Supplemental Information we believe to be of interest to investors, analysts and other parties includes the following:
Results Unaudited
The results in this document, together with the adjustments made to present the results on a comparable basis, have not been audited and are based on internal financial data furnished to management. Quarterly results should not be taken as an indication of the results of operations to be reported for any subsequent period or for the full fiscal year.
Table 1 Adjusted EBIT and Operating EBITDA - Reconciliation of Non-GAAP Measures - Unaudited |
||||||||||||||||||
|
Q1 '20 |
|
2019 |
|
Q4 '19 |
|
Q3 '19 |
|
Q2 '19 |
|
Q1 '19 |
|||||||
|
(In $ millions) |
|||||||||||||||||
Net earnings (loss) attributable to Celanese Corporation |
218 |
|
|
852 |
|
|
43 |
|
|
263 |
|
|
209 |
|
|
337 |
|
|
(Earnings) loss from discontinued operations |
7 |
|
|
6 |
|
|
(1 |
) |
|
5 |
|
|
1 |
|
|
1 |
|
|
Interest income |
(2 |
) |
|
(6 |
) |
|
(2 |
) |
|
(1 |
) |
|
(2 |
) |
|
(1 |
) |
|
Interest expense |
28 |
|
|
115 |
|
|
28 |
|
|
27 |
|
|
29 |
|
|
31 |
|
|
Refinancing expense |
— |
|
|
4 |
|
|
— |
|
|
— |
|
|
4 |
|
|
— |
|
|
Income tax provision (benefit) |
65 |
|
|
124 |
|
|
(3 |
) |
|
53 |
|
|
28 |
|
|
46 |
|
|
Certain Items attributable to Celanese Corporation (Table 8) |
26 |
|
|
381 |
|
|
238 |
|
|
29 |
|
|
107 |
|
|
7 |
|
|
Adjusted EBIT |
342 |
|
|
1,476 |
|
|
303 |
|
|
376 |
|
|
376 |
|
|
421 |
|
|
Depreciation and amortization expense(1) |
83 |
|
|
329 |
|
|
84 |
|
|
82 |
|
|
82 |
|
|
81 |
|
|
Operating EBITDA |
425 |
|
|
1,805 |
|
|
387 |
|
|
458 |
|
|
458 |
|
|
502 |
|
|
|
Q1 '20 |
|
2019 |
|
Q4 '19 |
|
Q3 '19 |
|
Q2 '19 |
|
Q1 '19 |
|||||||
|
(In $ millions) |
|||||||||||||||||
Engineered Materials |
2 |
|
|
4 |
|
|
2 |
|
|
1 |
|
|
— |
|
|
1 |
|
|
Acetate Tow |
— |
|
|
9 |
|
|
2 |
|
|
5 |
|
|
2 |
|
|
— |
|
|
Acetyl Chain |
— |
|
|
10 |
|
|
3 |
|
|
6 |
|
|
— |
|
|
1 |
|
|
Other Activities(2) |
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
Accelerated depreciation and amortization expense |
2 |
|
|
23 |
|
|
7 |
|
|
12 |
|
|
2 |
|
|
2 |
|
|
Depreciation and amortization expense(1) |
83 |
|
|
329 |
|
|
84 |
|
|
82 |
|
|
82 |
|
|
81 |
|
|
Total depreciation and amortization expense |
85 |
|
|
352 |
|
|
91 |
|
|
94 |
|
|
84 |
|
|
83 |
|
______________________________ | ||
(1) |
|
Excludes accelerated depreciation and amortization expense as detailed in the table above, which amounts are included in Certain Items above. |
(2) |
|
Other Activities includes corporate Selling, general and administrative ("SG&A") expenses, the results of captive insurance companies and certain components of net periodic benefit cost (interest cost, expected return on plan assets and net actuarial gains and losses) |
Table 2 - Supplemental Segment Data and Reconciliation of Segment Adjusted EBIT and Operating EBITDA - Non-GAAP Measures - Unaudited | ||||||||||||||||||||||||||||||||||||
|
Q1 '20 |
|
2019 |
|
Q4 '19 |
|
Q3 '19 |
|
Q2 '19 |
|
Q1 '19 |
|||||||||||||||||||||||||
|
(In $ millions, except percentages) |
|||||||||||||||||||||||||||||||||||
Operating Profit (Loss) / Operating Margin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Engineered Materials |
102 |
|
|
18.1 |
% |
|
446 |
|
|
18.7 |
% |
|
88 |
|
|
16.3 |
% |
|
111 |
|
|
18.8 |
% |
|
103 |
|
|
17.4 |
% |
|
144 |
|
|
21.7 |
% |
|
Acetate Tow |
27 |
|
|
20.9 |
% |
|
52 |
|
|
8.2 |
% |
|
22 |
|
|
14.9 |
% |
|
34 |
|
|
21.5 |
% |
|
(44 |
) |
|
(26.8 |
)% |
|
40 |
|
|
24.1 |
% |
|
Acetyl Chain(1) |
135 |
|
|
16.9 |
% |
|
678 |
|
|
20.0 |
% |
|
108 |
|
|
14.0 |
% |
|
180 |
|
|
20.8 |
% |
|
188 |
|
|
21.7 |
% |
|
202 |
|
|
22.7 |
% |
|
Other Activities(2) |
(70 |
) |
|
|
|
(342 |
) |
|
|
|
(150 |
) |
|
|
|
(65 |
) |
|
|
|
(61 |
) |
|
|
|
(66 |
) |
|
|
|||||||
Total |
194 |
|
|
13.3 |
% |
|
834 |
|
|
13.2 |
% |
|
68 |
|
|
4.7 |
% |
|
260 |
|
|
16.4 |
% |
|
186 |
|
|
11.7 |
% |
|
320 |
|
|
19.0 |
% |
|
Less: Net Earnings (Loss) Attributable to NCI(1) |
2 |
|
|
|
|
6 |
|
|
|
|
2 |
|
|
|
|
2 |
|
|
|
|
1 |
|
|
|
|
1 |
|
|
|
|||||||
Operating Profit (Loss) Attributable to Celanese Corporation |
192 |
|
|
13.2 |
% |
|
828 |
|
|
13.1 |
% |
|
66 |
|
|
4.6 |
% |
|
258 |
|
|
16.3 |
% |
|
185 |
|
|
11.6 |
% |
|
319 |
|
|
18.9 |
% |
|
Operating Profit (Loss) / Operating Margin Attributable to Celanese Corporation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Engineered Materials |
102 |
|
|
18.1 |
% |
|
446 |
|
|
18.7 |
% |
|
88 |
|
|
16.3 |
% |
|
111 |
|
|
18.8 |
% |
|
103 |
|
|
17.4 |
% |
|
144 |
|
|
21.7 |
% |
|
Acetate Tow |
27 |
|
|
20.9 |
% |
|
52 |
|
|
8.2 |
% |
|
22 |
|
|
14.9 |
% |
|
34 |
|
|
21.5 |
% |
|
(44 |
) |
|
(26.8 |
)% |
|
40 |
|
|
24.1 |
% |
|
Acetyl Chain(1) |
133 |
|
|
16.6 |
% |
|
672 |
|
|
19.8 |
% |
|
106 |
|
|
13.7 |
% |
|
178 |
|
|
20.5 |
% |
|
187 |
|
|
21.6 |
% |
|
201 |
|
|
22.6 |
% |
|
Other Activities(2) |
(70 |
) |
|
|
|
(342 |
) |
|
|
|
(150 |
) |
|
|
|
(65 |
) |
|
|
|
(61 |
) |
|
|
|
(66 |
) |
|
|
|||||||
Total |
192 |
|
|
13.2 |
% |
|
828 |
|
|
13.1 |
% |
|
66 |
|
|
4.6 |
% |
|
258 |
|
|
16.3 |
% |
|
185 |
|
|
11.6 |
% |
|
319 |
|
|
18.9 |
% |
|
Equity Earnings and Dividend Income, Other Income (Expense) Attributable to Celanese Corporation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Engineered Materials |
53 |
|
|
|
|
168 |
|
|
|
|
45 |
|
|
|
|
41 |
|
|
|
|
36 |
|
|
|
|
46 |
|
|
|
|||||||
Acetate Tow |
37 |
|
|
|
|
112 |
|
|
|
|
24 |
|
|
|
|
27 |
|
|
|
|
29 |
|
|
|
|
32 |
|
|
|
|||||||
Acetyl Chain |
1 |
|
|
|
|
5 |
|
|
|
|
1 |
|
|
|
|
2 |
|
|
|
|
1 |
|
|
|
|
1 |
|
|
|
|||||||
Other Activities(2) |
5 |
|
|
|
|
2 |
|
|
|
|
— |
|
|
|
|
2 |
|
|
|
|
1 |
|
|
|
|
(1 |
) |
|
|
|||||||
Total |
96 |
|
|
|
|
287 |
|
|
|
|
70 |
|
|
|
|
72 |
|
|
|
|
67 |
|
|
|
|
78 |
|
|
|
|||||||
Non-Operating Pension and Other Post-Retirement Employee Benefit (Expense) Income Attributable to Celanese Corporation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Engineered Materials |
— |
|
|
|
|
— |
|
|
|
|
— |
|
|
|
|
— |
|
|
|
|
— |
|
|
|
|
— |
|
|
|
|||||||
Acetate Tow |
— |
|
|
|
|
— |
|
|
|
|
— |
|
|
|
|
— |
|
|
|
|
— |
|
|
|
|
— |
|
|
|
|||||||
Acetyl Chain |
— |
|
|
|
|
— |
|
|
|
|
— |
|
|
|
|
— |
|
|
|
|
— |
|
|
|
|
— |
|
|
|
|||||||
Other Activities(2) |
28 |
|
|
|
|
(20 |
) |
|
|
|
(71 |
) |
|
|
|
17 |
|
|
|
|
17 |
|
|
|
|
17 |
|
|
|
|||||||
Total |
28 |
|
|
|
|
(20 |
) |
|
|
|
(71 |
) |
|
|
|
17 |
|
|
|
|
17 |
|
|
|
|
17 |
|
|
|
|||||||
Certain Items Attributable to Celanese Corporation (Table 8) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Engineered Materials |
10 |
|
|
|
|
7 |
|
|
|
|
3 |
|
|
|
|
2 |
|
|
|
|
9 |
|
|
|
|
(7 |
) |
|
|
|||||||
Acetate Tow |
3 |
|
|
|
|
104 |
|
|
|
|
8 |
|
|
|
|
10 |
|
|
|
|
86 |
|
|
|
|
— |
|
|
|
|||||||
Acetyl Chain |
5 |
|
|
|
|
50 |
|
|
|
|
37 |
|
|
|
|
11 |
|
|
|
|
1 |
|
|
|
|
1 |
|
|
|
|||||||
Other Activities(2) |
8 |
|
|
|
|
220 |
|
|
|
|
190 |
|
|
|
|
6 |
|
|
|
|
11 |
|
|
|
|
13 |
|
|
|
|||||||
Total |
26 |
|
|
|
|
381 |
|
|
|
|
238 |
|
|
|
|
29 |
|
|
|
|
107 |
|
|
|
|
7 |
|
|
|
|||||||
Adjusted EBIT / Adjusted EBIT Margin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Engineered Materials |
165 |
|
|
29.3 |
% |
|
621 |
|
|
26.0 |
% |
|
136 |
|
|
25.2 |
% |
|
154 |
|
|
26.1 |
% |
|
148 |
|
|
25.0 |
% |
|
183 |
|
|
27.6 |
% |
|
Acetate Tow |
67 |
|
|
51.9 |
% |
|
268 |
|
|
42.1 |
% |
|
54 |
|
|
36.5 |
% |
|
71 |
|
|
44.9 |
% |
|
71 |
|
|
43.3 |
% |
|
72 |
|
|
43.4 |
% |
|
Acetyl Chain |
139 |
|
|
17.4 |
% |
|
727 |
|
|
21.4 |
% |
|
144 |
|
|
18.7 |
% |
|
191 |
|
|
22.0 |
% |
|
189 |
|
|
21.8 |
% |
|
203 |
|
|
22.8 |
% |
|
Other Activities(2) |
(29 |
) |
|
|
|
(140 |
) |
|
|
|
(31 |
) |
|
|
|
(40 |
) |
|
|
|
(32 |
) |
|
|
|
(37 |
) |
|
|
|||||||
Total |
342 |
|
|
23.4 |
% |
|
1,476 |
|
|
23.4 |
% |
|
303 |
|
|
21.2 |
% |
|
376 |
|
|
23.7 |
% |
|
376 |
|
|
23.6 |
% |
|
421 |
|
|
25.0 |
% |
___________________________ | ||
(1) |
|
Net earnings (loss) attributable to NCI is included within the Acetyl Chain segment. |
(2) |
|
Other Activities includes corporate SG&A expenses, the results of captive insurance companies and certain components of net periodic benefit cost (interest cost, expected return on plan assets and net actuarial gains and losses). |
Table 2 - Supplemental Segment Data and Reconciliation of Segment Adjusted EBIT and Operating EBITDA - Non-GAAP Measures - Unaudited (cont.) |
||||||||||||||||||||||||||||||||||||
|
Q1 '20 |
|
2019 |
|
Q4 '19 |
|
Q3 '19 |
|
Q2 '19 |
|
Q1 '19 |
|||||||||||||||||||||||||
|
(In $ millions, except percentages) |
|||||||||||||||||||||||||||||||||||
Depreciation and Amortization Expense(1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Engineered Materials |
32 |
|
|
|
|
127 |
|
|
|
|
33 |
|
|
|
|
32 |
|
|
|
|
31 |
|
|
|
|
31 |
|
|
|
|||||||
Acetate Tow |
8 |
|
|
|
|
36 |
|
|
|
|
8 |
|
|
|
|
9 |
|
|
|
|
9 |
|
|
|
|
10 |
|
|
|
|||||||
Acetyl Chain |
39 |
|
|
|
|
151 |
|
|
|
|
39 |
|
|
|
|
37 |
|
|
|
|
38 |
|
|
|
|
37 |
|
|
|
|||||||
Other Activities(2) |
4 |
|
|
|
|
15 |
|
|
|
|
4 |
|
|
|
|
4 |
|
|
|
|
4 |
|
|
|
|
3 |
|
|
|
|||||||
Total |
83 |
|
|
|
|
329 |
|
|
|
|
84 |
|
|
|
|
82 |
|
|
|
|
82 |
|
|
|
|
81 |
|
|
|
|||||||
Operating EBITDA / Operating EBITDA Margin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Engineered Materials |
197 |
|
|
35.0 |
% |
|
748 |
|
|
31.3 |
% |
|
169 |
|
|
31.4 |
% |
|
186 |
|
|
31.5 |
% |
|
179 |
|
|
30.2 |
% |
|
214 |
|
|
32.3 |
% |
|
Acetate Tow |
75 |
|
|
58.1 |
% |
|
304 |
|
|
47.8 |
% |
|
62 |
|
|
41.9 |
% |
|
80 |
|
|
50.6 |
% |
|
80 |
|
|
48.8 |
% |
|
82 |
|
|
49.4 |
% |
|
Acetyl Chain |
178 |
|
|
22.3 |
% |
|
878 |
|
|
25.9 |
% |
|
183 |
|
|
23.7 |
% |
|
228 |
|
|
26.3 |
% |
|
227 |
|
|
26.2 |
% |
|
240 |
|
|
27.0 |
% |
|
Other Activities(2) |
(25 |
) |
|
|
|
(125 |
) |
|
|
|
(27 |
) |
|
|
|
(36 |
) |
|
|
|
(28 |
) |
|
|
|
(34 |
) |
|
|
|||||||
Total |
425 |
|
|
29.1 |
% |
|
1,805 |
|
|
28.7 |
% |
|
387 |
|
|
27.0 |
% |
|
458 |
|
|
28.9 |
% |
|
458 |
|
|
28.8 |
% |
|
502 |
|
|
29.8 |
% |
___________________________ | ||
(1) |
|
Excludes accelerated depreciation and amortization expense, which amounts are included in Certain Items above. See Table 1 for details. |
(2) |
|
Other Activities includes corporate SG&A expenses, the results of captive insurance companies and certain components of net periodic benefit cost (interest cost, expected return on plan assets and net actuarial gains and losses). |
Table 3 Adjusted Earnings (Loss) per Share - Reconciliation of a Non-GAAP Measure - Unaudited |
||||||||||||||||||||||||||||||||||||
|
Q1 '20 |
|
2019 |
|
Q4 '19 |
|
Q3 '19 |
|
Q2 '19 |
|
Q1 '19 |
|||||||||||||||||||||||||
|
|
|
per share |
|
|
|
per share |
|
|
|
per share |
|
|
|
per share |
|
|
|
per share |
|
|
|
per share |
|||||||||||||
|
(In $ millions, except per share data) |
|||||||||||||||||||||||||||||||||||
Earnings (loss) from continuing operations attributable to Celanese Corporation |
225 |
|
|
1.88 |
|
|
858 |
|
|
6.89 |
|
|
42 |
|
|
0.35 |
|
|
268 |
|
|
2.17 |
|
|
210 |
|
|
1.67 |
|
|
338 |
|
|
2.64 |
|
|
Income tax provision (benefit) |
65 |
|
|
|
|
124 |
|
|
|
|
(3 |
) |
|
|
|
53 |
|
|
|
|
28 |
|
|
|
|
46 |
|
|
|
|||||||
Earnings (loss) from continuing operations before tax |
290 |
|
|
|
|
982 |
|
|
|
|
39 |
|
|
|
|
321 |
|
|
|
|
238 |
|
|
|
|
384 |
|
|
|
|||||||
Certain Items attributable to Celanese Corporation (Table 8) |
26 |
|
|
|
|
381 |
|
|
|
|
238 |
|
|
|
|
29 |
|
|
|
|
107 |
|
|
|
|
7 |
|
|
|
|||||||
Refinancing and related expenses |
— |
|
|
|
|
4 |
|
|
|
|
— |
|
|
|
|
— |
|
|
|
|
4 |
|
|
|
|
— |
|
|
|
|||||||
Adjusted earnings (loss) from continuing operations before tax |
316 |
|
|
|
|
1,367 |
|
|
|
|
277 |
|
|
|
|
350 |
|
|
|
|
349 |
|
|
|
|
391 |
|
|
|
|||||||
Income tax (provision) benefit on adjusted earnings(1) |
(41 |
) |
|
|
|
(178 |
) |
|
|
|
(36 |
) |
|
|
|
(38 |
) |
|
|
|
(49 |
) |
|
|
|
(55 |
) |
|
|
|||||||
Adjusted earnings (loss) from continuing operations(2) |
275 |
|
|
2.29 |
|
|
1,189 |
|
|
9.53 |
|
|
241 |
|
|
1.99 |
|
|
312 |
|
|
2.53 |
|
|
300 |
|
|
2.38 |
|
|
336 |
|
|
2.62 |
|
|
|
Diluted shares (in millions)(3) |
|||||||||||||||||||||||||||||||||||
Weighted average shares outstanding |
119.3 |
|
|
|
|
123.9 |
|
|
|
|
120.3 |
|
|
|
|
122.7 |
|
|
|
|
125.3 |
|
|
|
|
127.5 |
|
|
|
|||||||
Incremental shares attributable to equity awards |
0.6 |
|
|
|
|
0.8 |
|
|
|
|
0.6 |
|
|
|
|
0.6 |
|
|
|
|
0.5 |
|
|
|
|
0.7 |
|
|
|
|||||||
Total diluted shares |
119.9 |
|
|
|
|
124.7 |
|
|
|
|
120.9 |
|
|
|
|
123.3 |
|
|
|
|
125.8 |
|
|
|
|
128.2 |
|
|
|
______________________________ | ||
(1) |
|
Calculated using adjusted effective tax rates (Table 3a) as follows: |
|
Q1 '20 |
|
2019 |
|
Q4 '19 |
|
Q3 '19 |
|
Q2 '19 |
|
Q1 '19 |
|||||||||||||||||||||||||
|
(In percentages) |
|||||||||||||||||||||||||||||||||||
Adjusted effective tax rate |
13 |
|
|
|
|
13 |
|
|
|
|
13 |
|
|
|
|
11 |
|
|
|
|
14 |
|
|
|
|
14 |
|
|
|
|||||||
(2) |
Excludes the immediate recognition of actuarial gains and losses and the impact of actual vs. expected plan asset returns. |
|
|
Actual Plan
|
|
Expected
|
||
|
|
(In percentages) |
||||
2019 |
|
16.7 |
|
|
6.5 |
|
(3) |
Potentially dilutive shares are included in the adjusted earnings per share calculation when adjusted earnings are positive. |
Table 3a Adjusted Tax Rate - Reconciliation of a Non-GAAP Measure - Unaudited |
||||||
|
Estimated |
|
Actual |
|||
|
2020 |
|
2019 |
|||
|
(In percentages) |
|||||
US GAAP annual effective tax rate |
17 |
|
|
13 |
|
|
Discrete quarterly recognition of GAAP items(1) |
(2 |
) |
|
— |
|
|
Tax impact of other charges and adjustments(2) |
(1 |
) |
|
— |
|
|
Utilization of foreign tax credits |
(1 |
) |
|
(3 |
) |
|
Changes in valuation allowances, excluding impact of other charges and adjustments(3) |
— |
|
|
3 |
|
|
Adjusted tax rate |
13 |
|
|
13 |
|
______________________________ |
||
Note: As part of the year-end reconciliation, we updated the reconciliation of the GAAP effective tax rate for actual results. |
||
(1) |
|
Such as changes in tax laws (including US tax reform), deferred taxes on outside basis differences, changes in uncertain tax positions and prior year audit adjustments. |
(2) |
|
Reflects the tax impact on pre-tax adjustments presented in Certain Items (Table 8), which are excluded from pre-tax income for adjusted earnings per share purposes. |
(3) |
|
Reflects changes in valuation allowances related to changes in judgment regarding the realizability of deferred tax assets or current year operations, excluding other charges and adjustments. |
Table 4 Net Sales by Segment - Unaudited |
||||||||||||||||||
|
Q1 '20 |
|
2019 |
|
Q4 '19 |
|
Q3 '19 |
|
Q2 '19 |
|
Q1 '19 |
|||||||
|
(In $ millions) |
|||||||||||||||||
Engineered Materials |
563 |
|
|
2,386 |
|
|
539 |
|
|
591 |
|
|
593 |
|
|
663 |
|
|
Acetate Tow |
129 |
|
|
636 |
|
|
148 |
|
|
158 |
|
|
164 |
|
|
166 |
|
|
Acetyl Chain |
799 |
|
|
3,392 |
|
|
771 |
|
|
867 |
|
|
865 |
|
|
889 |
|
|
Intersegment eliminations(1) |
(31 |
) |
|
(117 |
) |
|
(26 |
) |
|
(30 |
) |
|
(30 |
) |
|
(31 |
) |
|
Net sales |
1,460 |
|
|
6,297 |
|
|
1,432 |
|
|
1,586 |
|
|
1,592 |
|
|
1,687 |
|
___________________________ | ||
(1) |
|
Includes intersegment sales primarily related to the Acetyl Chain. |
Table 4a Factors Affecting Segment Net Sales Sequentially - Unaudited
|
||||||||||||||||
Three Months Ended March 31, 2020 Compared to Three Months Ended December 31, 2019 |
||||||||||||||||
|
Volume |
|
Price |
|
Currency |
|
Other |
|
Total |
|
||||||
|
(In percentages) |
|
||||||||||||||
Engineered Materials |
4 |
|
|
— |
|
|
— |
|
|
— |
|
|
4 |
|
|
|
Acetate Tow |
(9 |
) |
|
(4 |
) |
|
— |
|
|
— |
|
|
(13 |
) |
|
|
Acetyl Chain |
5 |
|
|
(1 |
) |
|
— |
|
|
— |
|
|
4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Company |
3 |
|
|
(1 |
) |
|
— |
|
|
— |
|
|
2 |
|
|
Three Months Ended December 31, 2019 Compared to Three Months Ended September 30, 2019 |
||||||||||||||||
|
Volume |
|
Price |
|
Currency |
|
Other |
|
Total |
|
||||||
|
(In percentages) |
|
||||||||||||||
Engineered Materials |
(9 |
) |
|
— |
|
|
— |
|
|
— |
|
|
(9 |
) |
|
|
Acetate Tow |
(6 |
) |
|
— |
|
|
— |
|
|
— |
|
|
(6 |
) |
|
|
Acetyl Chain |
(11 |
) |
|
— |
|
|
— |
|
|
— |
|
|
(11 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Company |
(10 |
) |
|
— |
|
|
— |
|
|
— |
|
|
(10 |
) |
|
Three Months Ended September 30, 2019 Compared to Three Months Ended June 30, 2019 |
||||||||||||||||
|
Volume |
|
Price |
|
Currency |
|
Other |
|
Total |
|
||||||
|
(In percentages) |
|
||||||||||||||
Engineered Materials |
2 |
|
|
(2 |
) |
|
(1 |
) |
|
— |
|
|
(1 |
) |
|
|
Acetate Tow |
(2 |
) |
|
(1 |
) |
|
— |
|
|
— |
|
|
(3 |
) |
|
|
Acetyl Chain |
1 |
|
|
— |
|
|
(1 |
) |
|
— |
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Company |
2 |
|
|
(1 |
) |
|
(1 |
) |
|
— |
|
|
— |
|
|
Three Months Ended June 30, 2019 Compared to Three Months Ended March 31, 2019 |
||||||||||||||||
|
Volume |
|
Price |
|
Currency |
|
Other |
|
Total |
|
||||||
|
(In percentages) |
|
||||||||||||||
Engineered Materials |
(7 |
) |
|
(3 |
) |
|
(1 |
) |
|
— |
|
|
(11 |
) |
|
|
Acetate Tow |
(1 |
) |
|
— |
|
|
— |
|
|
— |
|
|
(1 |
) |
|
|
Acetyl Chain |
2 |
|
|
(4 |
) |
|
(1 |
) |
|
— |
|
|
(3 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Company |
(2 |
) |
|
(3 |
) |
|
(1 |
) |
|
— |
|
|
(6 |
) |
|
Three Months Ended March 31, 2019 Compared to Three Months Ended December 31, 2018 |
||||||||||||||||
|
Volume |
|
Price |
|
Currency |
|
Other |
|
Total |
|
||||||
|
(In percentages) |
|
||||||||||||||
Engineered Materials |
5 |
|
|
2 |
|
|
— |
|
|
— |
|
|
7 |
|
(1) |
|
Acetate Tow |
1 |
|
|
2 |
|
|
— |
|
|
— |
|
|
3 |
|
|
|
Acetyl Chain |
5 |
|
|
(10 |
) |
|
— |
|
|
— |
|
|
(5 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Company |
5 |
|
|
(5 |
) |
|
— |
|
|
— |
|
|
— |
|
|
_________________________ | ||
(1) |
|
2019 includes the effect of the acquisition of Next Polymers Ltd. |
Table 4b Factors Affecting Segment Net Sales Year Over Year - Unaudited
|
|||||||||||||||
Three Months Ended March 31, 2020 Compared to Three Months Ended March 31, 2019 |
|||||||||||||||
|
Volume |
|
Price |
|
Currency |
|
Other |
|
Total |
||||||
|
(In percentages) |
||||||||||||||
Engineered Materials |
(9 |
) |
|
(5 |
) |
|
(1 |
) |
|
— |
|
|
(15 |
) |
|
Acetate Tow |
(17 |
) |
|
(5 |
) |
|
— |
|
|
— |
|
|
(22 |
) |
|
Acetyl Chain |
(3 |
) |
|
(7 |
) |
|
(1 |
) |
|
1 |
|
|
(10 |
) |
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Company |
(7 |
) |
|
(6 |
) |
|
(1 |
) |
|
1 |
|
|
(13 |
) |
Three Months Ended December 31, 2019 Compared to Three Months Ended December 31, 2018 |
|||||||||||||||
|
Volume |
|
Price |
|
Currency |
|
Other |
|
Total |
||||||
|
(In percentages) |
||||||||||||||
Engineered Materials |
(9 |
) |
|
(3 |
) |
|
(1 |
) |
|
— |
|
|
(13 |
) |
|
Acetate Tow |
(8 |
) |
|
— |
|
|
— |
|
|
— |
|
|
(8 |
) |
|
Acetyl Chain |
(4 |
) |
|
(13 |
) |
|
(1 |
) |
|
— |
|
|
(18 |
) |
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Company |
(6 |
) |
|
(8 |
) |
|
(1 |
) |
|
— |
|
|
(15 |
) |
Three Months Ended September 30, 2019 Compared to Three Months Ended September 30, 2018 |
|||||||||||||||
|
Volume |
|
Price |
|
Currency |
|
Other |
|
Total |
||||||
|
(In percentages) |
||||||||||||||
Engineered Materials |
(4 |
) |
|
(2 |
) |
|
(2 |
) |
|
— |
|
|
(8 |
) |
|
Acetate Tow |
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
Acetyl Chain |
6 |
|
|
(18 |
) |
|
(2 |
) |
|
— |
|
|
(14 |
) |
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Company |
2 |
|
|
(11 |
) |
|
(2 |
) |
|
1 |
|
|
(10 |
) |
Three Months Ended June 30, 2019 Compared to Three Months Ended June 30, 2018 |
|||||||||||||||
|
Volume |
|
Price |
|
Currency |
|
Other |
|
Total |
||||||
|
(In percentages) |
||||||||||||||
Engineered Materials |
(8 |
) |
|
— |
|
|
(3 |
) |
|
— |
|
|
(11 |
) |
|
Acetate Tow |
1 |
|
|
1 |
|
|
(1 |
) |
|
— |
|
|
1 |
|
|
Acetyl Chain |
(1 |
) |
|
(14 |
) |
|
(3 |
) |
|
— |
|
|
(18 |
) |
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Company |
(3 |
) |
|
(8 |
) |
|
(3 |
) |
|
— |
|
|
(14 |
) |
Three Months Ended March 31, 2019 Compared to Three Months Ended March 31, 2018 |
|||||||||||||||
|
Volume |
|
Price |
|
Currency |
|
Other |
|
Total |
||||||
|
(In percentages) |
||||||||||||||
Engineered Materials |
(3 |
) |
|
7 |
|
|
(4 |
) |
|
— |
|
|
— |
|
|
Acetate Tow |
(1 |
) |
|
— |
|
|
— |
|
|
— |
|
|
(1 |
) |
|
Acetyl Chain |
(4 |
) |
|
(8 |
) |
|
(3 |
) |
|
— |
|
|
(15 |
) |
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Company |
(3 |
) |
|
(2 |
) |
|
(4 |
) |
|
— |
|
|
(9 |
) |
Table 4c Factors Affecting Segment Net Sales Year Over Year - Unaudited
|
|||||||||||||||
Year Ended December 31, 2019 Compared to Year Ended December 31, 2018 |
|||||||||||||||
|
Volume |
|
Price |
|
Currency |
|
Other |
|
Total |
||||||
|
(In percentages) |
||||||||||||||
Engineered Materials |
(5 |
) |
|
— |
|
|
(3 |
) |
|
— |
|
|
(8 |
) |
|
Acetate Tow |
(2 |
) |
|
— |
|
|
— |
|
|
— |
|
|
(2 |
) |
|
Acetyl Chain |
(1 |
) |
|
(13 |
) |
|
(2 |
) |
|
— |
|
|
(16 |
) |
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Company |
(3 |
) |
|
(7 |
) |
|
(2 |
) |
|
— |
|
|
(12 |
) |
Table 5 Free Cash Flow - Reconciliation of a Non-GAAP Measure - Unaudited |
||||||||||||||||||
|
Q1 '20 |
|
2019 |
|
Q4 '19 |
|
Q3 '19 |
|
Q2 '19 |
|
Q1 '19 |
|||||||
|
(In $ millions, except percentages) |
|||||||||||||||||
Net cash provided by (used in) investing activities |
(128 |
) |
|
(493 |
) |
|
(168 |
) |
|
(82 |
) |
|
(66 |
) |
|
(177 |
) |
|
Net cash provided by (used in) financing activities |
(16 |
) |
|
(935 |
) |
|
(199 |
) |
|
(299 |
) |
|
(307 |
) |
|
(130 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Net cash provided by (used in) operating activities |
259 |
|
|
1,454 |
|
|
326 |
|
|
397 |
|
|
424 |
|
|
307 |
|
|
Capital expenditures on property, plant and equipment |
(119 |
) |
|
(370 |
) |
|
(144 |
) |
|
(82 |
) |
|
(65 |
) |
|
(79 |
) |
|
Distributions to NCI |
(5 |
) |
|
(10 |
) |
|
(3 |
) |
|
— |
|
|
(3 |
) |
|
(4 |
) |
|
Free cash flow(1)(2) |
135 |
|
|
1,074 |
|
|
179 |
|
|
315 |
|
|
356 |
|
|
224 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Net sales |
1,460 |
|
|
6,297 |
|
|
1,432 |
|
|
1,586 |
|
|
1,592 |
|
|
1,687 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Free cash flow as % of Net sales |
9.2 |
% |
|
17.1 |
% |
|
12.5 |
% |
|
19.9 |
% |
|
22.4 |
% |
|
13.3 |
% |
______________________________ | ||
(1) |
|
Free cash flow is a liquidity measure used by the Company and is defined by the Company as net cash provided by (used in) operating activities, less capital expenditures on property, plant and equipment, and adjusted for capital contributions from or distributions to Mitsui & Co., Ltd. ("Mitsui") related to our joint venture, Fairway Methanol LLC ("Fairway"). |
(2) |
|
Excludes required debt service and finance lease payments of $26 million and $24 million for the years ended December 31, 2020 and 2019, respectively. |
Table 6 Cash Dividends Received - Unaudited |
||||||||||||||||||
|
Q1 '20 |
|
2019 |
|
Q4 '19 |
|
Q3 '19 |
|
Q2 '19 |
|
Q1 '19 |
|||||||
|
(In $ millions) |
|||||||||||||||||
Dividends from equity method investments |
46 |
|
|
168 |
|
|
42 |
|
|
15 |
|
|
41 |
|
|
70 |
|
|
Dividends from equity investments without readily determinable fair values |
37 |
|
|
113 |
|
|
24 |
|
|
27 |
|
|
30 |
|
|
32 |
|
|
Total |
83 |
|
281 |
|
|
66 |
|
|
42 |
|
|
71 |
|
|
102 |
|
Table 7 Net Debt - Reconciliation of a Non-GAAP Measure - Unaudited |
||||||||||||||||||
|
Q1 '20 |
|
2019 |
|
Q4 '19 |
|
Q3 '19 |
|
Q2 '19 |
|
Q1 '19 |
|||||||
|
(In $ millions) |
|||||||||||||||||
Short-term borrowings and current installments of long-term debt - third party and affiliates |
749 |
|
|
496 |
|
|
496 |
|
|
368 |
|
|
319 |
|
|
743 |
|
|
Long-term debt, net of unamortized deferred financing costs |
3,356 |
|
|
3,409 |
|
|
3,409 |
|
|
3,359 |
|
|
3,444 |
|
|
2,933 |
|
|
Total debt |
4,105 |
|
|
3,905 |
|
|
3,905 |
|
|
3,727 |
|
|
3,763 |
|
|
3,676 |
|
|
Cash and cash equivalents |
(570 |
) |
|
(463 |
) |
|
(463 |
) |
|
(497 |
) |
|
(491 |
) |
|
(441 |
) |
|
Net debt |
3,535 |
|
3,442 |
|
3,442 |
|
3,230 |
|
3,272 |
|
3,235 |
|
Table 8 Certain Items - Unaudited
|
||||||||||||||||||||
The following Certain Items attributable to Celanese Corporation are included in Net earnings (loss) and are adjustments to non-GAAP measures: |
||||||||||||||||||||
|
Q1 '20 |
|
2019 |
|
Q4 '19 |
|
Q3 '19 |
|
Q2 '19 |
|
Q1 '19 |
|
Income Statement Classification |
|||||||
|
(In $ millions) |
|
|
|||||||||||||||||
Plant/office closures |
3 |
|
|
26 |
|
|
12 |
|
|
9 |
|
|
2 |
|
|
3 |
|
|
Cost of sales / SG&A / Other (charges) gains, net / Gain (loss) on disposition of businesses and assets, net |
|
Asset impairments |
4 |
|
|
94 |
|
(1) |
2 |
|
|
9 |
|
|
83 |
|
|
— |
|
|
Cost of sales / Other (charges) gains, net |
|
Clear Lake incident |
4 |
|
|
34 |
|
|
32 |
|
|
2 |
|
|
— |
|
|
— |
|
|
Cost of sales |
|
Mergers and acquisitions |
7 |
|
|
12 |
|
|
3 |
|
|
2 |
|
|
4 |
|
|
3 |
|
|
Cost of sales / SG&A |
|
Actuarial (gain) loss on pension and postretirement plans |
— |
|
|
88 |
|
|
88 |
|
|
— |
|
|
— |
|
|
— |
|
|
Cost of sales / SG&A / Non-operating pension and other postretirement employee benefit (expense) income |
|
Restructuring |
7 |
|
|
27 |
|
|
6 |
|
|
7 |
|
|
15 |
|
|
(1 |
) |
|
SG&A / Other (charges) gains, net / Non-operating pension and other postretirement employee benefit (expense) income |
|
European Commission investigation |
— |
|
|
89 |
|
|
89 |
|
|
— |
|
|
— |
|
|
— |
|
|
Other (charges) gains, net |
|
Commercial disputes |
— |
|
|
10 |
|
|
6 |
|
|
— |
|
|
2 |
|
|
2 |
|
|
Cost of sales / SG&A / Other (charges) gains, net |
|
Other |
1 |
|
|
1 |
|
|
— |
|
|
— |
|
|
1 |
|
|
— |
|
|
SG&A / Gain (loss) on disposition of businesses and assets, net |
|
Certain Items attributable to Celanese Corporation |
26 |
|
|
381 |
|
|
238 |
|
|
29 |
|
|
107 |
|
|
7 |
|
|
|
______________________________ | ||
(1) |
|
Includes $5 million of asset impairments in 2019 related to the Clear Lake incident. |
Table 9 Return on Invested Capital (Adjusted) - Presentation of a Non-GAAP Measure - Unaudited |
|||||||||
|
|
|
|
|
2019 |
||||
|
|
|
|
|
(In $ millions,
|
||||
Net earnings (loss) attributable to Celanese Corporation |
|
|
|
|
852 |
|
|||
|
|
|
|
|
|
||||
Adjusted EBIT (Table 1) |
|
|
|
|
1,476 |
|
|||
Adjusted effective tax rate (Table 3a) |
|
|
|
|
13 |
% |
|||
Adjusted EBIT tax effected |
|
|
|
|
1,284 |
|
|||
|
|
|
|
|
|
||||
|
2019 |
|
2018 |
|
Average |
||||
|
(In $ millions, except percentages) |
||||||||
Short-term borrowings and current installments of long-term debt - third parties and affiliates |
496 |
|
|
561 |
|
|
529 |
|
|
Long-term debt, net of unamortized deferred financing costs |
3,409 |
|
|
2,970 |
|
|
3,190 |
|
|
Celanese Corporation stockholders' equity |
2,507 |
|
|
2,984 |
|
|
2,746 |
|
|
Invested capital |
|
|
|
|
6,465 |
|
|||
|
|
|
|
|
|
||||
Return on invested capital (adjusted) |
|
|
|
|
19.9 |
% |
|||
|
|
|
|
|
|
||||
Net earnings (loss) attributable to Celanese Corporation as a percentage of invested capital |
|
|
|
|
13.2 |
% |
View source version on businesswire.com: https://www.businesswire.com/news/home/20200427005793/en/
Investor Relations
Abe Paul
Phone: +1 972 443 4432
[email protected]
Media - U.S.
Travis Jacobsen
Phone: +1 972 443 3750
[email protected]
Media - Europe
Petra Czugler
Phone: +49 174 762 8784
[email protected]